[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Chen T., Turner B.J., Beart P.M., Sheehan-Hennessy L., Elekwachi C., Muyderman H
Breeding trial Breeding trials started at 16 weeks of age
The secreted MMP-8, in turn, can activate other pro-inflammatory cytokines, further amplifying the cycle of ECM degradation
(Another DPP-4 inhibitor, vildagliptin, is widely prescribed in Europe but is not available in the U.S.) These agents are also available in combination with other diabetes medications (i.e., metformin, empagliflozin, pioglitazone, dapagliflozin, ertugliflozin)
For those reading this - 4 to 12mg comes with a lot of side effects that people arent discussing